Kenvue

In 2022, Johnson & Johnson announced the division of its business into two parts:

• A high-revenue but risky business of prescription drugs and medical devices.
• A business focused on consumer health products.

It was the second part of J&J's business that was transferred to its subsidiary company Kenvue. It is the world's largest company solely focused on consumer health products, with a net sales volume of $15.1 billion. The company's product portfolio includes well-known brands such as Tylenol, Neutrogena, Listerine, Johnson's, Band-Aid, Aveeno, Zyrtec, and Nicorette, which are recognized globally.